Abstract
The eosinophil is an enigmatic cell with a continuing ability to fascinate. A considerable history of research endeavor on eosinophil biology stretches from the present time back to the nineteenth century. Perhaps one of the most fascinating aspects of the eosinophil is how accumulating knowledge has changed the perception of its function from passive bystander, modulator of inflammation, to potent effector cell loaded with histotoxic substances through to more recent recognition that it can act as both a positive and negative regulator of complex events in both innate and adaptive immunity. This book consists of chapters written by experts in the field of eosinophil biology that provide comprehensive clearly written protocols for techniques designed to underpin research into the function of the eosinophil in health and disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ortega HG, Liu MC, Pavord ID et al (2014) Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 371(13):1198–1207
Nair P, Pizzichini MM, Kjarsgaard M et al (2013) Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 360(10):985–993
Rosenberg HF, Dyer KD, Foster PS (2013) Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 13(1):9–22
Walsh GM (2018) Reslizumab in the treatment of severe eosinophilic asthma: an update. Immunotherapy 10(8):695–698. https://doi.org/10.2217/imt-2017-0176
Bousquet J, Chanez P, Lacoste JY et al (1990) Eosinophilic inflammation in asthma. N Engl J Med 323(15):1033–1039
Walker C, Kaegi MK, Braun P, Blaser K (1991) Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 88(6):935–942
Davoine F, Lacy P (2014) Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol 5:570
Nissim Ben Efraim AH, Levi-Schaffer F (2008) Tissue remodeling and angiogenesis in asthma: the role of the eosinophil. Ther Adv Respir Dis 2(3):163–171
Akuthota P, Wang H, Weller PF (2010) Eosinophils as antigen-presenting cells in allergic upper airway disease. Curr Opin Allergy Clin Immunol 10(1):14–19
Farhan RK, Vickers MA, Ghaemmaghami AM, Hall AM, Barker RN, Walsh GM (2016) Effective antigen presentation to helper T cells by human eosinophils. Immunology 149(4):413–422. https://doi.org/10.1111/imm.12658
Rosenberg HF, Phipps S, Foster PS (2007) Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 119(6):1303–1310. quiz 1311-1302
Walsh GM (2010) Antagonism of eosinophil accumulation in asthma. Recent Patents Inflamm Allergy Drug Discov 4(3):210–213
Matsumoto K, Bochner BS (2013) Adhesion molecules. In: Lee JJ, Rosenberg HF (eds) Eosinophils in health and disease. Elsevier, New York, pp 131–139
Wu P, Mitchell S, Walsh GM (2005) A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin Exp Allergy 35(8):1073–1079
Robinson AJ, Kashanin D, O’Dowd F, Williams V, Walsh GM (2008) Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT(1)R antagonism. J Leukoc Biol 83(6):1522–1529
Robinson AJ, Kashanin D, O’Dowd F, Fitzgerald K, Williams V, Walsh GM (2009) Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions. Clin Exp Allergy 39(12):1866–1874
Walsh GM (2013) Eosinophil apoptosis and clearance in asthma. J Cell Death 6:17–25
Gounni AS, Gregory B, Nutku E et al (2000) Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood 96(6):2163–2171
Esnault S, Kelly EA (2016) Essential mechanisms of differential activation of eosinophils by IL-3 compared to GM-CSF and IL-5. Crit Rev Immunol 36(5):429–444
Leung DY (1998) Molecular basis of allergic diseases. Mol Genet Metab 63(3):157–167
Cheung PF, Wong CK, Ip WK, Lam CW (2006) IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy 61(7):878–885
Suzukawa M, Koketsu R, Iikura M (2008) Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Investig 88(11):1245–1253
Wong CK, Hu S, Cheung PF, Lam CW (2010) Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol 43(3):305–315
Anwar AR, Moqbel R, Walsh GM, Kay AB, Wardlaw AJ (1993) Adhesion to fibronectin prolongs eosinophil survival. J Exp Med 177(3):839–843
Hogan SP, Rosenberg HF, Moqbel R et al (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38(5):709–750
Dvorak AM, Furitsu T, Letourneau L, Ishizaka T, Ackerman SJ (1991) Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein. Am J Pathol 138(1):69–82
Spencer LA, Bonjour K, Melo RC, Weller PF (2014) Eosinophil secretion of granule-derived cytokines. Front Immunol 5:496
Peters MS, Rodriguez M, Gleich GJ (1986) Localization of human eosinophil granule major basic protein, eosinophil cationic protein and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Investig 54(6):656–662
Lewis DM, Lewis JC, Loegering DA, Gleich GJ (1978) Localization of the guinea pig eosinophil major basic protein to the core of the granule. J Cell Biol 77(3):702–713
Lacy P, Moqbel R (2013) Signaling and degranulation. In: Lee JJ, Rosenberg HF (eds) Eosinophils in health and disease. Elsevier, New York, pp 206–219
Lacy P, Nair P (2019) The human eosinophil. In: Greer JP, Rodgers GM, Glader B, Arber DA, Means RT, List AF, Appelbaum FR, Dispenzieri A, Fehniger TA (eds) Wintrobe’s clinical hematology. Wolters Kluwer, Philadelphia, PA, pp 167–190
Lacy P, Stow JL (2011) Cytokine release from innate immune cells: association with diverse membrane trafficking pathways. Blood 118(1):9–18
Erjefalt JS, Persson CG (2000) New aspects of degranulation and fates of airway mucosal eosinophils. Am J Respir Crit Care Med 161(6):2074–2085
Saffari H, Hoffman LH, Peterson KA et al (2014) Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. J Allergy Clin Immunol 133(6):1728–1734
Radonjic-Hoesli S, Wang X, de Graauw E et al (2017) Adhesion-induced eosinophil cytolysis requires the receptor-interacting protein kinase 3 (RIPK3)-mixed lineage kinase-like (MLKL) signaling pathway, which is counterregulated by autophagy. J Allergy Clin Immunol 140(6):1632–1642
Driss V, Legrand F, Capron M (2013) Eosinophil receptor profile. In: Lee JJ, Rosenberg HF (eds) Eosinophils in heatlh and disease. Elsevier, New York, pp 30–38
Kita H (2013) Antifungal immunity by Eosinophils: mechanisms and implications in human diseases. In: Lee JJ, Rosenberg HF (eds) Eosinophils in health and disease. Elsevier, New York, pp 291–299
Adamko DJ, Wu Y, Gleich GJ, Lacy P, Moqbel R (2004) The induction of eosinophil peroxidase release: improved methods of measurement and stimulation. J Immunol Methods 291(1–2):101–108
Melo RC, Perez SA, Spencer LA, Dvorak AM, Weller PF (2005) Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. Traffic 6(10):866–879
Melo RC, Weller PF (2010) Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses. Histol Histopathol 25(10):1341–1354
Lacy P, Mahmudi-Azer S, Bablitz B et al (1999) Rapid mobilization of intracellularly stored RANTES in response to interferon-gamma in human eosinophils. Blood 94(1):23–32
Spencer LA, Melo RC, Perez SA, Bafford SP, Dvorak AM, Weller PF (2006) Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc Natl Acad Sci U S A 103(9):3333–3338
Lacy P, Willetts L, Kim JD et al (2011) Agonist activation of f-actin-mediated eosinophil shape change and mediator release is dependent on Rac2. Int Arch Allergy Immunol 156(2):137–147
Lacy P, Logan MR, Bablitz B, Moqbel R (2001) Fusion protein vesicle-associated membrane protein 2 is implicated in IFN-gamma-induced piecemeal degranulation in human eosinophils from atopic individuals. J Allergy Clin Immunol 107(4):671–678
Logan MR, Lacy P, Bablitz B, Moqbel R (2002) Expression of eosinophil target SNAREs as potential cognate receptors for vesicle-associated membrane protein-2 in exocytosis. J Allergy Clin Immunol 109(2):299–306
Logan MR, Lacy P, Odemuyiwa SO et al (2006) A critical role for vesicle-associated membrane protein-7 in exocytosis from human eosinophils and neutrophils. Allergy 61(6):777–784
Kim JD, Willetts L, Ochkur S et al (2013) An essential role for Rab27a GTPase in eosinophil exocytosis. J Leukoc Biol 94(6):1265–1274
Willetts L, Felix LC, Jacobsen EA et al (2018) Vesicle-associated membrane protein 7-mediated eosinophil degranulation promotes allergic airway inflammation in mice. Commun Biol 1:83
McLaren DJ, Mackenzie CD, Ramalho-Pinto FJ (1977) Ultrastructural observations on the in vitro interaction between rat eosinophils and some parasitic helminths (Schistosoma mansoni, Trichinella spiralis and Nippostrongylus brasiliensis). Clin Exp Immunol 30(1):105–118
Gentil K, Hoerauf A, Layland LE (2013) Eosinophil-mediated responses toward Helminths. In: Lee JJ, Rosenberg HF (eds) Eosinophils in health and disease. Elsevier, New York, pp 303–312
Foster PS, Rosenberg HF, Asquith KL et al (2008) Targeting eosinophils in asthma. Curr Mol Med 8:585–590
Walsh GM (2015) Mepolizumab based therapy in asthma – an update. Curr Opin Allergy Clin Immunol 15:392–396
Cushen B, Menzies-Gow A (2020) Benralizumab: an updated treatment of eosinophilic asthma. Expert Rev Respir Med 2020(17):1–10
Figueiredo RT, Neves JS (2018) Eosinophils in fungal diseases: An overview. J Leukoc Biol 104(1):49–60. https://doi.org/10.1002/JLB.4MR1117-473R
Nutman TB (2013) Immune responses in Helminth infections. In: Lee JJ, Rosenberg HF (eds) Eosinophils in health and disease. Elsevier, New York, pp 312–320
Rosenberg HF, Dyer KD, Domachowske JB (2013) Interactions of eosinophils with respiratory virus pathogens. In: Lee JJ, Rosenberg HF (eds) Eosinophils in health and disease. Elsevier, New York, pp 281–290
Yousefi S, Simon D, Simon HU (2012) Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. Curr Opin Immunol 24(6):736–739
Swartz JM, Dyer KD, Cheever AW et al (2006) Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood 108:2420–2427
Huang L, Appleton JA (2016) Eosinophils in helminth infection: defenders and dupes. Trends Parasitol 32(10):798–807
Percopo CM, Dyer KD, Ochkur SI et al (2014) Activated mouse eosinophils protect against lethal respiratory virus infection. Blood 30(5):123, 743–152
Samarasinghe AE, Melo RC, Duan S et al (2017) Eosinophils promote antiviral immunity in mice infected with influenza A virus. J Immunol 198(8):3214–3226
Rosenberg HF, Masterson JC, Furuta GT (2016) Eosinophils, probiotics, and the microbiome. J Leukoc Biol 100(5):881–888
Evans RL, Nials AT, Knowles RG et al (2012) A comparison of antiasthma drugs between acute and chronic ovalbumin-challenged Guinea-pig models of asthma. Pulm Pharmacol Ther 25:453–464
Rosenberg HF, Druey KM (2018) Modelling asthma: Pitfalls, promises, and the road ahead. J Leuk Biol 104(1):41–48
Lee JJ, Jacobsen EA, Ochkur SI et al (2012) Human versus mouse eosinophils: “that which we call an eosinophil, by any other name would stain as red”. J Allergy Clin Immunol 130:572–584
Lee NA (2012) Mouse models manipulating eosinophilopoiesis. In: Lee JJ, Rosenberg HF (eds) Eosinophils in health and disease. Elsevier, Waltham, MA, pp 111–120
Dent LA, Strath M, Mellor AL, Sanderson CJ (1990) Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 172:1425–1431
Ochkur SI, Jacobsen EA, Protheroe CA et al (2007) Co-expression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. J Immunol 78:7879–7889
Kopf M, Brombacher F, Hodgkin PD et al (1996) IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15–24
Yoshida T, Ikuta K, Sugaya H et al (1996) Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity 4:483–494
Yu C, Cantor AB, Yang H et al (2002) Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 195:1387–1395
Nei Y, Obata-Ninomiya K, Tsutsui H et al (2013) GATA-1 regulates the generation and function of basophils. Proc Natl Acad Sci U S A 110:18620–18625
Lee JJ, Dimina D, Macias MP et al (2004) Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305:1773–1776
Jacobsen EA, Lesuer WE, Willetts L (2014) Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice. Allergy 69(3):315–327
Doyle AD, Jacobsen EA, Ochkur SI et al (2013) Homologous recombination into the eosinophil peroxidase locus generates a strain of mice expressing Cre recombinase exclusively in eosinophils. J Leuk Biol 94:17–24
O’Sullivan JA, Wei Y, Carroll DJ et al (2018) Frontline Science: characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils. J Leukoc Biol 104(1):11–19
Rosenberg HF (2013) Mouse eosinophils expressing Cre recombinase: endless “flox”ibilities. J Leuk Biol 94:3–4
Lee JJ, Jacobsen EA, McGarry MP et al (2010) Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy 40:563–575
Akuthota P, Wang HB, Spencer LA, Weller PF (2008) Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy 38:1254–1263
Wang HB, Ghiran I, Matthae K, Weller PF (2007) Airway eosinophils: allergic inflammation recruited professional antigen presenting cells. J Immunol 179:7585–7592
Wang HB (2008) Weller PF (2008) pivotal advance: eosinophils mediate early alum adjuvant elicited B cell priming and IgM production. J Leuk Biol 83:817–821
Chu VT, Fröhlich A, Steinhauser G et al (2011) Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol 12:151–159
Wu D, Molofsky AB, Liang HE et al (2011) Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332:243–247
Yang D, Chen Q, Su SB et al (2008) Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med 205:79–90
Minai-Fleminger Y, Levi-Schaffer F (2009) Mast cells and eosinophils: the two key effector cells in allergic inflammation. Inflamm Res 58:631–638
Haskell MD, Moy JN, Gleich GJ, Thomas LL (1995) Analysis of signalling events associated with activation of neutrophil superoxide anion production by eosinophil granule major basic protein. Blood 86:4627–4637
Klion AD, Nutman TB (2004) The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 113:30–37
Fabre V, Beiting DP, Bliss SK et al (2009) Eosinophil deficiency compromises parasite survival in chronic nematode infection. J Immunol 182:1577–1583
Gebreselassie NG, Moorhead AR, Fabre V (2012) Eosinophils preserve parasitic nematode larvae by regulating local immunity. J Immunol 188:417–425
Noor Z, Watanabe K, Abhyankar MM et al (2017, 2017) Role of eosinophils and tumor necrosis factor alpha in interleukin-25-mediated protection from amoebic colitis. mBio 8(1):e02329
Buonomo EL, Cowardin CA, Wilson MG et al (2016) Microbiota-regulated IL-25 increases eosinophil number to provide protection during Clostridium difficile infection. Cell Rep 16(2):432–443
Reichman H, Karo-Atar D, Munitz A (2016) Emerging roles for eosinophils in the tumor microenvironment. Trends Cancer 2(11):664–675
Mesnil C, Raulier S, Paulissen G et al (2016) Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest 126(9):3279–3295
Weller PF, Spencer LA (2017) Functions of tissue-resident eosinophils. Nat Rev Immunol 17(12):746–760
Mehta P, Furuta GT (2015) Eosinophils in gastrointestinal disorders: eosinophilic gastrointestinal diseases, celiac disease, inflammatory bowel diseases and parasitic infections. Immunol Allergy Clin N Am 35(3):413–437
Rosenberg HF, Dyer KD, Domachowske JB (2009) Respiratory viruses and eosinophils: exploring the connections. Antivir Res 83:1–9
Yousefi S, Gold JA, Andina N et al (2008) Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 14:949–953
Linch SN, Danielson ET, Kelly AM et al (2012) Interleukin 5 is protective during sepsis in an eosinophil-independent manner. Am J Respir Crit Care Med 186:246–254
Herbst T, Sichelstiel A, Schar C et al (2011) Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med 184:198–205
Bisgaard H, Li N, Bonnelykke K (2011) Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 128:646–652
Drake MG, Lebold KM, Roth-Carter QR et al (2018) Eosinophil and airway nerve interactions in asthma. J Leuk Biol 104(1):61–67
Acknowledgments
This work is supported in part by funds from NIAID DIR AI000941 (HFR).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Lacy, P., Rosenberg, H.F., Walsh, G.M. (2021). Molecular Biology of Eosinophils: Introduction. In: Walsh, G.M. (eds) Eosinophils. Methods in Molecular Biology, vol 2241. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1095-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1095-4_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1094-7
Online ISBN: 978-1-0716-1095-4
eBook Packages: Springer Protocols